JD Health International
$34.64Change from previous close: −3.78%Absolute change: −$1.36
Valuation
Data as of October 4, 2026
Valuation multiples
- Market cap
- $110.49B
- Enterprise value
- $61.67B
- P/E (trailing 12 months)
- 15.3
- Forward P/E
- 11.8
- PEG
- 1.43
- Price/book
- 1.54
- Price/sales
- 1.40
- EV/EBITDA
- 12.1
- EV/revenue
- 0.78
Profitability and growth
- Gross margin
- 25.3%
- Operating margin
- 7.8%
- Net margin
- 7.9%
- ROE
- 10.4%
- ROA
- 3.7%
- ROIC
- 31.1%
- Revenue growth (year over year)
- 15.9%
- Earnings growth (year over year)
- 32.1%
Financial health
- Total cash
- $49.27B
- Total debt
- $874.85M
- Debt/equity
- 0.01
- Current ratio
- 2.69
- Quick ratio
- 2.33
- Altman Z-Score
- 5.73
- Piotroski F-Score
- 6.00
Dividends
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- $68.37
- Median price target
- $66.98
- High price target
- $95.75
- Low price target
- $49.80
- Analysts with a price target
- 16
- Consensus
- Strong buy
- Forward EPS
- $2.95
- EPS estimate, current year
- $2.13
Shares and trading
- Beta
- 1.18
- Average volume
- 9.09M
- Shares outstanding
- 3.19B
- Float
- 1.01B
- Institutional ownership
- 16.6%
- Insider ownership
- 68.2%